Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis in Brittle Nail Syndrome
NCT01064830Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Feb 2010
- Primary completion
- Aug 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine ophthalmic solution in brittle nail syndrome (BNS), sponsored by University of North Carolina at Chapel Hill. Started Feb 2010; status: completed.
02
Drugs
cyclosporine ophthalmic solution
03
Conditions
brittle nail syndrome (BNS)
Beyond the preview
Go deeper on NCT01064830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01064830.